Rajbhandari J, Fernandez CJ, Agarwal M, Yeap BXY, Pappachan JM. Diabetic heart disease: A clinical update. World J Diabetes 2021; 12(4): 383-406 [PMID: 33889286 DOI: 10.4239/wjd.v12.i4.383]
Corresponding Author of This Article
Joseph M Pappachan, FRCP, MD, Consultant Physician-Scientist, Honorary Research Fellow, Senior Researcher, Department of Endocrinology and Metabolism, Lancashire Teaching Hospitals NHS Trust, Royal Preston Hospital, Sharoe Green Lane, Preston PR2 9HT, United Kingdom. drpappachan@yahoo.co.in
Research Domain of This Article
Endocrinology & Metabolism
Article-Type of This Article
Review
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
World J Diabetes. Apr 15, 2021; 12(4): 383-406 Published online Apr 15, 2021. doi: 10.4239/wjd.v12.i4.383
Diabetic heart disease: A clinical update
Jake Rajbhandari, Cornelius James Fernandez, Mayuri Agarwal, Beverly Xin Yi Yeap, Joseph M Pappachan
Jake Rajbhandari, College of Medical and Dental Sciences, University of Birmingham Medical School, Birmingham B15 2TH, United Kingdom
Cornelius James Fernandez, Mayuri Agarwal, Department of Endocrinology and Metabolism, Pilgrim Hospital, Boston PE21 9QS, United Kingdom
Beverly Xin Yi Yeap, Department of Medicine, The University of Manchester Medical School, Manchester M13 9PL, United Kingdom
Joseph M Pappachan, Department of Endocrinology and Metabolism, Lancashire Teaching Hospitals NHS Trust, Preston PR2 9HT, United Kingdom
Joseph M Pappachan, Faculty of Science, Manchester Metropolitan University, Manchester M15 6BH, United Kingdom
Joseph M Pappachan, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester M13 9PL, United Kingdom
Author contributions: Rajbhandari J and Fernandez CJ performed majority of the initial drafting, prepared the figures and tables, and share the first authorship of the paper; Agarwal M and Yeap BXY did additional literature search and made critical revisions in the write up; Pappachan JM conceived the idea, made critical revisions and provided final approval of the final version of the manuscript to be published.
Conflict-of-interest statement: Authors have no conflicts of interest in relation to this article.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Joseph M Pappachan, FRCP, MD, Consultant Physician-Scientist, Honorary Research Fellow, Senior Researcher, Department of Endocrinology and Metabolism, Lancashire Teaching Hospitals NHS Trust, Royal Preston Hospital, Sharoe Green Lane, Preston PR2 9HT, United Kingdom. drpappachan@yahoo.co.in
Received: January 25, 2021 Peer-review started: January 25, 2021 First decision: February 25, 2021 Revised: February 27, 2021 Accepted: March 13, 2021 Article in press: March 13, 2021 Published online: April 15, 2021 Processing time: 73 Days and 13.2 Hours
Core Tip
Core Tip: Cardiovascular disease is the major cause of morbidity and mortality among patients with diabetes mellitus (DM). Three distinct and common clinical entities viz., coronary artery disease (CAD), cardiac autonomic neuropathy (CAN) and diabetic cardiomyopathy (DCM) collectively form diabetic heart disease. The pathophysiological mechanisms involved in the development of diabetic heart disease are complex and involve multiple metabolic and molecular pathways. Although most clinicians are well-aware that CAD is a cardiac complication of DM, the awareness about CAN and DCM is remarkably low. This clinical update discusses the pathophysiology, diagnostic aspects, and management options for patients with diabetic heart disease, to empower clinicians across the globe to optimally manage the disease scientifically.
